
Investments
45Portfolio Exits
21Funds
3About Point72 Asset Management
Point72 Asset Management operates as a family office managing the assets of its founder, Steven A. Cohen, and certain eligible employees. It focuses primarily on discretionary long or short equity investing and makes quantitative and macro investments. It was formerly known as SAC Capital Advisors and changed its name to Point72 Asset Management. The firm was founded in 1992 and is based in Stamford, Connecticut.

Want to inform investors similar to Point72 Asset Management about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Point72 Asset Management News
Sep 18, 2023
Opinions expressed by Digital Journal contributors are their own. In a groundbreaking move that signals institutional interest in the burgeoning field of psychedelics, Point72 Asset Management and its founder, billionaire investor Steve Cohen, have acquired 18.95 million beneficially owned shares of Cybin Inc. ( NYSEAMERICAN: CYBN ). The announcement came via an SEC Schedule 13G form, which is filed when a party’s ownership of stock exceeds 5% of a company’s total stock issue. The filing also revealed that Point72 Asset Management now holds an impressive portfolio value of $33.62 billion, underlining its significant influence in the investment world. Image courtesy Point72 Asset Management The Psychedelic Frontier Cybin Inc. is at the forefront of the rapidly expanding psychedelics industry, focusing on developing therapies that leverage psychedelic substances to treat mental health disorders such as depression, anxiety, and PTSD. The move by Point72 and Steve Cohen signifies not just a bet on Cybin, but a high-profile endorsement of the entire psychedelics sector. What This Means for Cybin The acquisition of nearly 19 million shares by a behemoth like Point72 brings significant attention and credibility to Cybin. As institutional investors typically conduct meticulous due diligence before taking such large positions, Point72’s investment can be seen as a significant vote of confidence in Cybin’s future prospects. A Calculated Risk It’s no secret that the field of psychedelics carries with it an array of uncertainties, from regulatory hurdles to the stigma attached to psychedelic substances. However, initial studies have shown promising results in using psychedelics for medical treatment, and public sentiment seems to be gradually shifting. Cohen and Point72 seem to be calculating that the risk will yield high returns in the long run. Photo courtesy Point72 Asset Management Industry Ramifications Point72’s investment could serve as a catalyst for more institutional money to flow into the psychedelics sector. Already, various startups and established companies are working on medical applications for psychedelic substances, from microdosing LSD for treating depression to using psilocybin—the active compound in magic mushrooms—for anxiety relief. Cohen and Point72 joining the fray could be a sign that the industry is maturing and becoming increasingly attractive to major investors. Looking Ahead While the regulatory landscape for psychedelics remains a wild card, the investment by Point72 and Steve Cohen seems to herald a pivotal moment for the industry. As one of the most significant endorsements to date, this could trigger a chain reaction that leads to more capital, research, and ultimately, mainstream acceptance of psychedelics as a viable treatment for mental health disorders. For an industry that has long been on the fringes of medical science, the move by Point72 and Steve Cohen could be the nudge it needs to step into the spotlight. Disclosure: The information presented in this article is based on public records and should not be considered financial advice.
Point72 Asset Management Investments
45 Investments
Point72 Asset Management has made 45 investments. Their latest investment was in MediWound as part of their PIPE - II on February 2, 2023.

Point72 Asset Management Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
2/5/2023 | PIPE - II | MediWound | $27.5M | Yes | 2 | |
9/27/2022 | Series D | Unravel | $50M | Yes | 3 | |
8/10/2022 | Series C | Boulevard | $70M | Yes | 8 | |
1/5/2022 | Series B | |||||
9/14/2021 | Seed |
Date | 2/5/2023 | 9/27/2022 | 8/10/2022 | 1/5/2022 | 9/14/2021 |
---|---|---|---|---|---|
Round | PIPE - II | Series D | Series C | Series B | Seed |
Company | MediWound | Unravel | Boulevard | ||
Amount | $27.5M | $50M | $70M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 3 | 8 |
Point72 Asset Management Portfolio Exits
21 Portfolio Exits
Point72 Asset Management has 21 portfolio exits. Their latest portfolio exit was Korro Bio on July 14, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
7/14/2023 | Acq - Pending | 3 | |||
8/2/2022 | Shareholder Liquidity | 1 | |||
3/12/2021 | IPO | Public | 1 | ||
Date | 7/14/2023 | 8/2/2022 | 3/12/2021 | ||
---|---|---|---|---|---|
Exit | Acq - Pending | Shareholder Liquidity | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 3 | 1 | 1 |
Point72 Asset Management Acquisitions
3 Acquisitions
Point72 Asset Management acquired 3 companies. Their latest acquisition was Neways Enterprises on January 20, 2012.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
1/20/2012 | Debt | Acq - Fin - II | ||||
4/9/2010 | Series C | |||||
8/18/2007 | Private Equity |
Date | 1/20/2012 | 4/9/2010 | 8/18/2007 |
---|---|---|---|
Investment Stage | Debt | Series C | Private Equity |
Companies | |||
Valuation | |||
Total Funding | |||
Note | Acq - Fin - II | ||
Sources |
Point72 Asset Management Fund History
3 Fund Histories
Point72 Asset Management has 3 funds, including Point72 Private Equity Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
11/16/2021 | Point72 Private Equity Fund | $600M | 1 | ||
Point72 Select | |||||
Altere Capital |
Closing Date | 11/16/2021 | ||
---|---|---|---|
Fund | Point72 Private Equity Fund | Point72 Select | Altere Capital |
Fund Type | |||
Status | |||
Amount | $600M | ||
Sources | 1 |
Point72 Asset Management Team
22 Team Members
Point72 Asset Management has 22 team members, including current Chief Information Officer, Seetharam Gorre.
Name | Work History | Title | Status |
---|---|---|---|
Seetharam Gorre | Citadel, and SAC Capital | Chief Information Officer | Current |
Name | Seetharam Gorre | ||||
---|---|---|---|---|---|
Work History | Citadel, and SAC Capital | ||||
Title | Chief Information Officer | ||||
Status | Current |